𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Can NK cells be a therapeutic target in human type 1 diabetes?

✍ Scribed by Francesco Dotta; Cecilia Fondelli; Alberto Falorni


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
73 KB
Volume
38
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Type 1 diabetes is caused by the autoimmune destruction of insulin‐producing cells with consequent hyperglycemia and serious chronic complications. Both innate and adaptive immune responses participate in disease pathogenesis. Studies in animal models and in man have shown that NK cells are involved both in disease progression and in disease protection, thus suggesting that NK cells can represent a potential therapeutic target in type 1 diabetes, once the contribution of these cells to islet autoimmunity has been fully elucidated.


📜 SIMILAR VOLUMES


Can NK cells be a therapeutic target in
✍ Christopher J. Chan; Daniel M. Andrews; Mark J. Smyth 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

## Abstract Our current knowledge of NK‐cell recognition and effector function suggests that it will be possible to design various new NK‐cell‐based immunotherapies against human cancer. The application of NK cells is already showing promise using HLA‐mismatched haematopoietic stem cell transplanta

Angiotensin II type 1 receptor as a nove
✍ A. Price; J. C. Lockhart; W. R. Ferrell; W. Gsell; S. McLean; R. D. Sturrock 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract ## Objective Angiotensin II (Ang II) is known to have proinflammatory actions, and Ang II type 1 (AT~1~) receptors are up‐regulated in the rheumatoid synovium, suggesting that this receptor could be a therapeutic target. The purpose of this study was to investigate the antiinflammatory

Stable human T-cell lymphotropic virus t
✍ Maria E. Eirin; Carolina A. Berini; Leandro R. Jones; Dario A. Dilernia; Alberto 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

## Abstract Jujuy province, in Northwest Argentina, is known to be endemic for HTLV‐1 infection. Moreover, foci of HTLV‐1 associated pathologies have also been described in this region. To gain an insight into the current situation of HTLV‐1/2 in this endemic area, a seroprevalence and phylogenetic